EIKONIZO THERAPEUTICS

Eikonizo Therapeutics, Inc. was founded in October 2017 based on discoveries from Dr. Jacob Hooker’s academic lab (at MGH (Massachusetts General Hospital) and the Martinos Center for Biomedical Imaging) around novel small molecule design and human PET neuroimaging agents. ‘Eikonizo’ (ee-kuh-NEE-zo) is Greek for ‘envision’ or ‘imagine’. It captures their strategy to use PET imaging early in the drug discovery process to de-risk novel targets and lead therapeutic candidates, allowing... us to envision an accelerated path to drug discovery and development. This is especially needed for brain diseases, where drug development is typically hampered by the inability to measure whether a drug has even gotten to the brain. They’re applying this approach in their lead project focusing on novel small molecule therapeutics for neurodegenerative diseases, such as Alzheimer’s Disease and ALS.

#SimilarOrganizations #People #Website #More

EIKONIZO THERAPEUTICS

Industry:

Biotechnology Health Care Pharmaceutical

Founded:

2017-01-01

Address:

Beverly, Massachusetts, United States

Country:

United States

Website Url:

http://www.eikonizo.com

Total Employee:

Status:

Active

Contact:

(617) 308-4405

Total Funding:

2 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Wordpress Plugins